Pfizer is proud to introduce the CANADIAN Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) 2018 Breast Cancer Research Awards, a Competitive Grants Program Supported by Pfizer for investigators in Canada.
Call for Research Proposals
For complete information about the program, please visit ASPIRE website www.canadaaspire.org
AREA OF RESEARCH FOCUS
Pfizer invites investigators to apply for the 2018 Canadian ASPIRE Breast Cancer Research Awards through submission of innovative clinical research proposals designed to accomplish the mission of advancing knowledge in the treatment and disease management of breast cancer.
The 2018 Canadian ASPIRE Breast Cancer Research Awards Program will have 2 categories of Award(s):
Breast Cancer Research Award
Early Investigator Award (within 5 years of residency completion for MD, or 5 years of 1st faculty position for non-MD).
The maximum budget allowed per proposal will be $200,000 (including a maximum of 30% overhead).
The 2018 Canadian ASPIRE Breast Cancer Research Awards Program intends to fund at least 2 proposals.
Winners expected to be announced by the end of January 2019.
SUBMISSIONS ARE DUE BY
September 24, 2018